E.g., 21/06/2021
E.g., 21/06/2021

Cepheid and bioMérieux enter into strategic commercial program

06 January, 2004

Cepheid (NASDAQ: CPHD) today announced that it has entered into a strategic commercial relationship with bioMerieux for bioMerieux to develop DNA testing products embodying its proprietary NASBA (Nucleic Acid Sequence-Based Amplification) technology to be run on...